Mostafa Hashemi

Mr. Mostafa Hashemi

Chemical and Biological Engineering, University of British Columbia, Vancouver, British Columbia, Canada
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BABrianna Atto
Brianna Atto
YAYitayal Anteneh
Yitayal Anteneh
SBSeweryn Bialasiewicz
Seweryn Bialasiewicz
MBMICHAEL BINKS
MICHAEL BINKS
MHMostafa Hashemi
Mostafa Hashemi
RMRobyn L. Marsh
Robyn L. Marsh
Chronic wet cough for longer than 4 weeks is a hallmark of chronic suppurative lung diseases (CSLD), including protracted bacterial bronchitis (PBB), and bronchiectasis in children. Severe lower respiratory infection early in life is a major risk factor of PBB and paediatric bronchiectasis. In these conditions, failure to clear an underlying endobronchial infection is hypothesised to drive ongoing inflammation and progressive tissue damage that culminates in irreversible bronchiectasis. Historically, the microbiology of paediatric chronic wet cough has been defined by culture-based studies focused on the detection and eradication of specific bacterial pathogens. Various ‘omics technologies now allow for a more nuanced investigation of respiratory pathobiology and are enabling development of endotype-based models of care. Recent years have seen substantial advances in defining respiratory endotypes among adults with CSLD; however, less is understood about diseases affecting children. In this review, we explore the current understanding of the airway microbiome among children with chronic wet cough related to the PBB–bronchiectasis diagnostic continuum. We explore concepts emerging from the gut–lung axis and multi-omic studies that are expected to influence PBB and bronchiectasis endotyping efforts. We also consider how our evolving understanding of the airway microbiome is translating to new approaches in chronic wet cough diagnostics and treatments.

12 March 2025 in Journal of Breath Research
Verified
Journal Article
Open access
RMRobyn L. Marsh
Robyn L. Marsh
MHMostafa Hashemi
Mostafa Hashemi
MMMiza Mwanza
Miza Mwanza
HOHannah O'Farrell
Hannah O'Farrell
LVLesley A Versteegh
Lesley A Versteegh
Jane Emily HillJane Emily Hill
Jane Emily Hill
Breath volatile organic compounds (VOCs) are increasingly under consideration as biomarkers of respiratory disease. Although numerous studies have identified VOCs that distinguish patient groups, a lack of standardisation among published studies has impeded translation into clinical diagnostics. Standardised breath collection protocols have been proposed for adults and children aged >4 years, but optimal methods for collecting breath from younger children remain to be determined. The aim of this study was to assess the feasibility and acceptability of breath sampling among a young paediatric cohort. A total of 61 children (age 6 months–12 years) were recruited prospectively to observational studies of chronic cough at two study sites. Mixed expiratory breath was collected into 1 l Tedlar Bags using either a drinking straw, mouthpiece, or mask. After concentrating onto thermal desorption tubes, the breath was analysed using two-dimensional gas chromatography coupled with time-of-flight mass spectrometry. Breath collection via a mouthpiece was highly feasible for children aged >2 years. Mask-based collection was required for younger children but was poorly tolerated. Drinking straw-based collections were unsuitable for some children aged <4 years due to challenges maintaining a sufficient seal. At least 700 ml of breath was sampled from 72.6% of children. The number of peaks per sample, total peak area per sample, and composition of breath VOCs were all consistent with successful breath sampling. The high feasibility of breath collection via a mouthpiece in our study suggests established protocols designed for children aged over 4 years can be used with confidence for children from as young as 2 years of age.

16 November 2026 in Journal of Breath Research
Verified
Journal Article
Open access
AGAntao Gao
Antao Gao
JAJosephine Ackah-Cudjoe
Josephine Ackah-Cudjoe
MHMostafa Hashemi
Mostafa Hashemi
SDSamantha L Durfey
Samantha L Durfey
EMEdward F McKone
Edward F McKone
Jane Emily HillJane Emily Hill
Jane Emily Hill
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have revolutionized cystic fibrosis (CF) management, but airway infections and inflammation persist. This study evaluates longitudinal exhaled breath profiles and identifies volatile organic compounds (VOCs) that correlate with sputum bacterial load and neutrophil elastase (NE) levels during ivacaftor and/or antibiotic treatment. Eight people with CF (pwCF) with a heterozygous R117H CFTR mutation and chronic lung infection with P. aeruginosa ( Pa ) and/or S. aureus (Sa) were enrolled in a longitudinal study at St. Vincent’s University Hospital in Dublin, Ireland. Breath samples and sputum samples were collected at multiple time points. Correlation analyses were performed between VOC abundances and bacterial load or NE levels. We observed temporal changes in breath profile across the eight subjects during the ivacaftor and/or antibiotic treatment. Within Pa -infected subjects, 54 VOCs showed consistent directional Pearson correlation and at least moderate repeated measures correlation (rmcorr) coefficient ( r rm ) with bacterial load, including the 12 VOCs previously reported as Pa -associated markers. Similarly, within Sa- infected subjects, we identified eight VOCs that showed consistent directional correlation and at least moderate r rm with bacterial load, including four previously reported Sa -associated markers. Additionally, we identified 7 exploratory VOC candidates that consistently correlated with changes in NE levels, each demonstrating agenerally weak r rm across eight subjects. This study demonstrates that breath profiles of pwCF change over time during ivacaftor and/or antibiotic treatment. Identifying specific breath VOCs whose levels correlate with Pa or Sa CFU/ml, as well as NE levels, supports further evaluation of exhaled breath VOCs as non-invasive markers for monitoring airway infection and inflammation in pwCF.

1 October 2026 in Journal of Breath Research
Verified
Journal Article
Open access
MHMostafa Hashemi
Mostafa Hashemi
MSMarek Svoboda
Marek Svoboda
FFFlavio A Franchina
Flavio A Franchina
Jane Emily HillJane Emily Hill
Jane Emily Hill
Exercise induces metabolic and physiological changes across multiple organs. These changes have been studied via several human biofluids, including urine and blood; however, they remain mainly underexplored in exhaled breath. In this exploratory pilot study, we performed untargeted profiling of breath volatile compounds (VCs) to investigate how exercise and recovery influence breath chemical composition. Breath samples were collected from 71 university athletes from three sporting disciplines. Across 143 breath samples, a total of 1204 unique breath VCs were detected. There were distinct volatilomic responses to physical activity and recovery, regardless of the athlete ’ s sport. Comparison of paired samples using volcano analysis collected before and during exercise identified 80 breath VCs that significantly increased and 182 that significantly decreased. Similarly, a comparison of samples collected before and after exercise identified 11 compounds that decreased significantly. These findings demonstrate that exercise induces measurable changes in the breath volatilome. However, due to the lack of standardized exercise intensity measures and physiological monitoring, the results should be considered exploratory and interpreted cautiously within the field of exercise science.